Vcanbio Cell & Gene Engineering Corp., Ltd (600645.SS)

CNY 21.47

(6.93%)

Operating Income Summary of Vcanbio Cell & Gene Engineering Corp., Ltd

  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest annual operating income in 2023 was 131.12 Million CNY , down -15.95% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd's latest quarterly operating income in 2024 Q3 was 62.35 Million CNY , up 7.66% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported an annual operating income of 156 Million CNY in 2022, down -29.02% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported an annual operating income of 219.79 Million CNY in 2021, up 24.96% from previous year.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a quarterly operating income of 62.35 Million CNY for 2024 Q3, up 7.66% from previous quarter.
  • Vcanbio Cell & Gene Engineering Corp., Ltd reported a quarterly operating income of 57.91 Million CNY for 2024 Q2, up 8.92% from previous quarter.

Annual Operating Income Chart of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1993)

Historical Annual Operating Income of Vcanbio Cell & Gene Engineering Corp., Ltd (2023 - 1993)

Year Operating Income Operating Income Growth
2023 131.12 Million CNY -15.95%
2022 156 Million CNY -29.02%
2021 219.79 Million CNY 24.96%
2020 175.89 Million CNY -2.75%
2019 180.86 Million CNY 77.04%
2018 102.16 Million CNY 462.49%
2017 18.16 Million CNY -77.44%
2016 80.52 Million CNY -68.09%
2015 252.37 Million CNY 344.01%
2014 56.83 Million CNY 1505.9%
2013 3.53 Million CNY -87.54%
2012 28.41 Million CNY -48.38%
2011 55.03 Million CNY 32.46%
2010 41.55 Million CNY 88.08%
2009 22.09 Million CNY -11.15%
2008 24.86 Million CNY -45.03%
2007 45.23 Million CNY 1265.66%
2006 3.31 Million CNY 106.39%
2005 -51.84 Million CNY 17.21%
2004 -62.62 Million CNY -850.9%
2003 8.33 Million CNY 115.95%
2002 -52.28 Million CNY -565.2%
2001 11.23 Million CNY -79.55%
2000 54.94 Million CNY 465.26%
1999 9.71 Million CNY -65.3%
1998 28.01 Million CNY -27.01%
1997 38.37 Million CNY 37.33%
1996 27.94 Million CNY 20.57%
1995 23.17 Million CNY -33.59%
1994 34.89 Million CNY 57.8%
1993 22.11 Million CNY 0.0%

Peer Operating Income Comparison of Vcanbio Cell & Gene Engineering Corp., Ltd

Name Operating Income Operating Income Difference
Beijing Tiantan Biological Products Co., Ltd. 1.8 Billion CNY 92.735%
JiangSu WuZhong Pharmaceutical Development Co., Ltd. -32.57 Million CNY 502.475%
Jinyu Bio-technology Co., Ltd. 315.2 Million CNY 58.401%
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong 1.18 Billion CNY 88.932%
Zhejiang Ausun Pharmaceutical Co., Ltd. 290.82 Million CNY 54.913%
DaShenLin Pharmaceutical Group Co., Ltd. 1.63 Billion CNY 91.965%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. 1.4 Billion CNY 90.644%
GuiZhou SanLi Pharmaceutical Co.,Ltd 335.82 Million CNY 60.955%
Pulike Biological Engineering, Inc. 193.01 Million CNY 32.065%
Beijing Konruns Pharmaceutical Co.,Ltd. 143.28 Million CNY 8.486%
Shanghai Hile Bio-Technology Co., Ltd. 55.17 Million CNY -137.671%
Qingdao Vland Biotech INC. 122.9 Million CNY -6.692%
Zhejiang Shouxiangu Pharmaceutical Co., Ltd. 254.72 Million CNY 48.523%
Aurisco Pharmaceutical Co.,Ltd. 330.72 Million CNY 60.353%
Zhejiang East Asia Pharmaceutical Co., Ltd. 136.97 Million CNY 4.268%
Hainan Huluwa Pharmaceutical Group Co., Ltd. 136.93 Million CNY 4.245%
Mabwell (Shanghai) Bioscience Co., Ltd. -1.05 Billion CNY 112.455%
Beijing Hotgen Biotech Co., Ltd. 17.21 Million CNY -661.894%
Assure Tech (Hangzhou) Co., Ltd. 167.48 Million CNY 21.709%
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. 189.66 Million CNY 30.865%
Cabio Biotech (Wuhan) Co., Ltd. 81.6 Million CNY -60.682%
Shanghai Shen Lian Biomedical Corporation 36.11 Million CNY -263.037%
Nanjing Vazyme Biotech Co., Ltd. -100.18 Million CNY 230.889%
Shandong Kexing Bioproducts Co,.Ltd -254.2 Million CNY 151.583%
Shanghai Junshi Biosciences Co., Ltd. -2.45 Billion CNY 105.336%
Shanghai Model Organisms Center, Inc. -29.8 Million CNY 539.997%
Suzhou Zelgen Biopharmaceuticals Co., Ltd. -408.79 Million CNY 132.076%
Xiamen Amoytop Biotech Co., Ltd. 680.72 Million CNY 80.737%
Novogene Co., Ltd. 214.87 Million CNY 38.978%
Shanghai ZJ Bio-Tech Co., Ltd. -149.49 Million CNY 187.709%
Chengdu Olymvax Biopharmaceuticals Inc. 3.4 Million CNY -3754.008%
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd 318.21 Million CNY 58.794%
Shanghai Haohai Biological Technology Co., Ltd. 507.41 Million CNY 74.158%
Jiangsu Bioperfectus Technologies Co., Ltd. -382.77 Million CNY 134.256%
Jiangsu Aidea Pharmaceutical Co., Ltd. -98.34 Million CNY 233.331%
Chengdu Easton Biopharmaceuticals Co., Ltd. 241.73 Million CNY 45.757%
Sinocelltech Group Limited 6.36 Million CNY -1959.892%
Wuhan Keqian Biology Co.,Ltd 459.13 Million CNY 71.441%
Shanghai Allist Pharmaceuticals Co., Ltd. 657.66 Million CNY 80.062%
Anhui Huaheng Biotechnology Co., Ltd. 510.9 Million CNY 74.335%
Youcare Pharmaceutical Group Co., Ltd. 231.75 Million CNY 43.421%
Jiangsu gdk Biotechnology Co., Ltd. -81.67 Million CNY 260.553%
Beijing Kawin Technology Share-Holding Co., Ltd. 170.82 Million CNY 23.242%
Hangzhou Biotest Biotech Co.,Ltd. 116.82 Million CNY -12.241%